Data / Form D filings / Vyriad, Inc.
Vyriad, Inc.: Form D filing
Vyriad, Inc., a biotechnology company in Rochester, MN, filed a Form D with the SEC in 2019. The latest, on November 14, 2019, reports $24.4 million sold of a $37.8 million offering to 10 investors.
Find out what Vyriad, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2900 37th Street NW, Building 110, Rochester, MN, 55901
- Phone
- (507) 289-0944
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1794098
The full lists. Form D filings in Minnesota: 692 rows, $34.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 14, 2019 | New notice | $37,800,000 | $24,376,966 | $13,423,034 | 10 | Oct 30, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen J. Russell, MD, PhD | Executive Officer, Director, Promoter | |
| Kah-Whye S. Peng, PhD | Executive Officer | |
| James J. Hannon | Executive Officer | |
| Glen N. Barber | Director, Promoter | |
| Ahryon N. Cho | Director | |
| Andrew N. Khoo | Director | |
| Edwin M. Kania, Jr. | Director | |
| Nathan L. Stacy | Director | |
| Alice S. Bexon, MD | Executive Officer |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- EyeMacular Regeneration, Inc. $2.9 million · Sep 25, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Nov 11, 2019 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Vyriad, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.